Amanda Smith celebrates the day, August 1, nearly two years ago, when she stopped taking insulin to manage her type one diabetes, just a few months after getting a dose of experimental stem cells as part of a study.
  • FoxyFerengi@startrek.website
    6·
    5 days ago

    But there’s a tradeoff. The patients, however, require immune-suppressing drugs for life, so that the immune system doesn’t destroy the cells.

    That was my question on reading the headline. Type 1 diabetes is an immune disorder, what they did here is replace the cells that had been killed by the immune system.

    A second patient, according to the study, died of severe dementia.

    Also, wtf. Why did they allow a patient with severe dementia into the study? If it’s only a one or two year long study that person would have been displaying dementia already and likely couldn’t actually consent to it